… Venous thromboembolism (VTE) represents one of the most important causes of morbidity
and mortality in cancer patients. According to population-based case–control studies, the 2-…

… of venous thromboembolism (VTE) in cancer patients may have changed in the past decade,
possibly due to novel cancer … 499 092 patients with a first-time cancer diagnosis between …

… assess the individual risk of thrombosis for cancer patients. Thus, we examined and questioned
cancer patients at the Department of Internal Medicine (Cancer Research) of the Essen …

… For a relatively similar type of surgery, post-operative VTE occurs 2–3 times more frequently
in cancer patients than in non cancer patients. In cancer patients undergoing surgery …

… cancer and venous thromboembolism (VTE) is well-established. Up to 20% of cancer patients
develop VTE, which is recognized as one of the leading causes of death in these patients. …

… Currently, primary prevention of venous thrombosis should be considered for cancer
patients during and immediately after chemotherapy, when long-term indwelling central venous …

… Patients undergoing surgery for cancer … cancer patients compared with patients without
cancer. Furthermore, the risk of recurrence after a first episode of VTE is higher in cancer patients …

Background People with cancer are known to be at increased risk of venous thromboembolism
(VTE), and this risk is believed to vary according to cancer type, stage of disease, and …

… and treatment of venous thromboembolism in patients with cancer. These drugs … patients
with more favourable outlook. About 10% of patients with idiopathic venous thromboembolism …

… The magnitude of the risk for venous thromboembolism (VTE) is well established for … in
patients with malignant disease.Venous thromboembolism may be the first sign of an oc- …